Development of an Efficient Process for a Key Synthetic Intermediate of the SGLT2 Inhibitor LH-1801

• Jun Qu,
• Zhong Hu,
• Pengcheng Zhang,
• Hongxiang Wu,
• Honglan Xue,
• Lei Cai,
• Xingxing Sun,
• Yun Qian,
• Rongrong Peng,
• Dehua Gao

Affiliations

Jun Qu

Center for Drug Design and Development, Yangzhou Princechem Co., Ltd., Yangzhou, People's Republic of China

Zhong Hu

Yangzhou Key Laboratory of New Pharmaceutical Intermediates, Yangzhou Princechem Co., Ltd., Yangzhou, People's Republic of China

Pengcheng Zhang

Center for Drug Design and Development, Yangzhou Princechem Co., Ltd., Yangzhou, People's Republic of China

Hongxiang Wu

Center for Drug Design and Development, Yangzhou Princechem Co., Ltd., Yangzhou, People's Republic of China

Honglan Xue

Center for Drug Design and Development, Yangzhou Princechem Co., Ltd., Yangzhou, People's Republic of China

Lei Cai

Center for Drug Design and Development, Yangzhou Princechem Co., Ltd., Yangzhou, People's Republic of China

Xingxing Sun

Center for Drug Design and Development, Yangzhou Princechem Co., Ltd., Yangzhou, People's Republic of China

Yun Qian

Yangzhou Key Laboratory of New Pharmaceutical Intermediates, Yangzhou Princechem Co., Ltd., Yangzhou, People's Republic of China

Rongrong Peng

Yangzhou Key Laboratory of New Pharmaceutical Intermediates, Yangzhou Princechem Co., Ltd., Yangzhou, People's Republic of China

Dehua Gao

Center for Drug Design and Development, Yangzhou Princechem Co., Ltd., Yangzhou, People's Republic of China